In pooled analyses of the STEP-HFpEF (Semaglutide Treatment Effect in People with obesity and HFpEF) and STEP-HFpEF-DM trials, GLP-1 RA had consistent beneficial effects on HF-related symptoms, exercise function, and inflammatory markers in patients receiving diuretics with obesity-related HFpEF [82]
Perna, S., Guido, D., Bologna, C., Solerte, S
All treatments are non-invasive, medically supervised, and customized to fit your comfort and pace.
Incremental Increases: To achieve the desired effect in weight management, your dose may be increased gradually
Such reports are only able to generate hypotheses and cannot establish definitive proof of therapeutic efficacy
If you have a client thats taking GLP-1s, whats something you want them to look out for